PHIO PHARMACEUTICALS CORP. Stock Split Ratio
PHIO PHARMACEUTICALS CORP. (PHIO) reported Stock Split Ratio of 1.82% for the 3-month period ending 2020-03-31, per its 10-Q filed 2020-08-12.
Discontinued › Notes › Stockholders' Equity Note
us-gaap:StockholdersEquityNoteStockSplitConversionRatio1 · last filed 2020-08-12
- PHIO PHARMACEUTICALS CORP. stockholders' equity note, stock split, conversion ratio for the quarter ending 2020-03-31 was 1.82%.
- PHIO PHARMACEUTICALS CORP. stockholders' equity note, stock split, conversion ratio for the quarter ending 2014-03-31 was 3.30%.
- PHIO PHARMACEUTICALS CORP. stockholders' equity note, stock split, conversion ratio for fiscal 2013 was 3.30%.
| Period end | Stockholders' Equity Note, Stock Split, Conversion Ratio 0 month | Stockholders' Equity Note, Stock Split, Conversion Ratio | Stockholders' Equity Note, Stock Split, Conversion Ratio 1 month | Stockholders' Equity Note, Stock Split, Conversion Ratio 3 month | Stockholders' Equity Note, Stock Split, Conversion Ratio 9 month | Stockholders' Equity Note, Stock Split, Conversion Ratio 12 month |
|---|---|---|---|---|---|---|
| 2020-03-31 | 1.82% 10-Q · filed 2020-08-12 | |||||
| 2020-01-15 | 1.82% 10-Q · filed 2020-08-12 | |||||
| 2018-01-03 | 0.10% 10-K · filed 2019-03-27 | 0.10% 10-Q · filed 2018-05-10 | ||||
| 2016-04-14 | 10.00% 10-Q · filed 2016-11-10 | |||||
| 2014-03-31 | 3.30% 10-Q · filed 2014-05-14 | |||||
| 2013-12-31 | 3.30% 10-K · filed 2015-03-30 | |||||
| 2013-09-30 | 3.30% 10-Q · filed 2014-11-13 | |||||
| 2013-07-18 | 3.30% 10-K · filed 2014-03-28 | 3.30% 10-Q · filed 2013-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |